Molecular Templates, Inc. (MTEM) Social Stream
MOLECULAR TEMPLATES INC (MTEM) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering MOLECULAR TEMPLATES INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-19 | 6 | $18 | $12 | $13.6 | $3.73 | 264.61% |
| 2021-12-02 | 6 | $14 | $9 | $12 | $3.73 | 221.72% |
| 2022-03-09 | 4 | $14 | $9 | $11.75 | $3.73 | 215.01% |
| 2022-03-28 | 5 | $14 | $9 | $11.5 | $3.73 | 208.31% |
| 2022-03-30 | 5 | $14 | $4.5 | $9.9 | $3.73 | 165.42% |
| 2022-05-12 | 5 | $14 | $4.5 | $9.5 | $3.73 | 154.69% |
| 2022-05-13 | 5 | $14 | $4.5 | $9.1 | $3.73 | 143.97% |
| 2022-07-18 | 5 | $14 | $1.5 | $7.6 | $3.73 | 103.75% |
| 2022-08-11 | 5 | $12 | $1.5 | $7.2 | $3.73 | 93.03% |
| 2022-09-17 | 5 | $12 | $1.5 | $6.4 | $3.73 | 71.58% |
| 2023-02-08 | 5 | $12 | $1 | $5.875 | $3.73 | 57.51% |
| 2023-03-10 | 4 | $12 | $1 | $5.875 | $3.73 | 57.51% |
| 2023-03-31 | 4 | $9 | $1 | $3.625 | $3.73 | -2.82% |
| 2023-04-04 | 3 | $3 | $0.5 | $1.5 | $3.73 | -59.79% |
| 2023-04-10 | 4 | $4.5 | $0.5 | $2.25 | $3.73 | -39.68% |
| 2023-06-02 | 3 | $1 | $0.5 | $0.833 | $3.73 | -77.67% |
| 2023-08-10 | 2 | $14.992 | $7.496 | $11.244 | $3.73 | 201.45% |
The Trend in the Analyst Price Target
Over the past 24 months, MTEM's average price target has gone down $13.75.
Over the past 28 weeks, MTEM's average upside potential has been 501.69%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-08 | 4 | 12.000 | 1.000 | 5.875 | 0.491 | 1096.54% |
| 2023-02-08 | 5 | 12.000 | 1.000 | 5.875 | 0.491 | 1096.54% |
| 2023-03-31 | 4 | 9.000 | 1.000 | 3.625 | 0.380 | 853.95% |
| 2023-08-10 | 2 | 1.000 | 0.500 | 0.750 | 0.590 | 27.12% |
| 2023-08-10 | 2 | 14.992 | 7.496 | 11.244 | 0.590 | 1805.76% |
MTEM Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.5 | 1 | 0 | 0 | 0 | 0 | 2 |
The Trend in the Broker Recommendations
Over the past 16 months, MTEM's average broker recommendation rating worsened by 1.5.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for MTEM as an investment opportunity.
- MTEM has a greater average analyst price target than 180.03% of all US stocks.
- MOLECULAR TEMPLATES INC's upside potential (average analyst target price relative to current price) is higher than 1449.56% of all US stocks.
- MOLECULAR TEMPLATES INC's number of analysts covering the stock is greater than 366.08% of all US stocks.
- In the context of Pharmaceutical Products stocks, MOLECULAR TEMPLATES INC's variance in analysts' estimates is lower than -1259.82% of them.
In the Pharmaceutical Products industry, LUMO, CPIX, and DRRX are the three stocks most similar to MOLECULAR TEMPLATES INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Make investment decisions regarding MTEM using the data that counts. Try POWR Ratings for free.